Mayumi Sako

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

Koichi Kamei, Shuichi Ito, Kandai Nozu et al. · Pediatric Nephrology · 2009 · 175 citations

Medicine, Nephrology, Pediatrics +10

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

Norishige Yoshikawa, Koichi Nakanishi, Mayumi Sako et al. · Kidney International · 2014 · 132 citations · Full text

Medicine, Nephrology, Pediatrics +14

Validity of the Oxford classification of IgA nephropathy in children

Yuko Shima, Koichi Nakanishi, Taketsugu Hama et al. · Pediatric Nephrology · 2011 · 114 citations

Medicine, Nephrology, Pediatrics +14

Rituximab for refractory focal segmental glomerulosclerosis

Makiko Nakayama, Koichi Kamei, Kandai Nozu et al. · Pediatric Nephrology · 2007 · 104 citations

Medicine, Nephrology, Pharmacotherapy +11